Western blot analysis performed on the expression profiles of the MTOR signal cascade in the tumor adjacent tissues revealed that the treated group expressed a lower level of MTOR/EIF4EBP1/YY1/MYC/SLC2A1 signaling than the untreated group (Fig. 5C). This evidence concerns the gene SLC2A1 and neoplasm.